Skinvisible, Inc. (SKVI)
Stock Price:
$0.0550 USD
0.0000 (0.00%)
Updated Oct 16, 2020 9:30 AM EDT - Market closed
Key Info
| Market Cap |
245,946 |
| Revenue (ttm) |
158,104 |
| Net Income (ttm) |
-1.52M |
| Shares Out |
4.47M |
| EPS (ttm) |
-0.41 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 16, 2020 |
| Last Price |
$0.0550 |
| Previous Close |
$0.0550 |
| Change ($) |
0.0000 |
| Change (%) |
0.00% |
| Day's Open |
0.0550 |
| Day's Range |
0.0550 - 0.0550 |
| Day's Volume |
0 |
| 52-Week Range |
0.016 - 0.187 |
More Stats
| Market Cap |
245,946 |
| Enterprise Value |
2.64M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
4.47M |
| Float |
4.28M |
| EPS (basic) |
-0.42 |
| EPS (diluted) |
-0.41 |
| FCF / Share |
0.01 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
23.16% |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
0.14 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
4.32 |
| PS Ratio |
1.56 |
| PB Ratio |
n/a |
| Revenue |
158,104 |
| Operating Income |
-397,143 |
| Net Income |
-1.52M |
| Free Cash Flow |
56,973 |
| Net Cash |
-2.40M |
| Net Cash / Share |
-0.54 |
| Gross Margin |
16.20% |
| Operating Margin |
-251.19% |
| Profit Margin |
-960.70% |
| FCF Margin |
36.04% |
| ROA |
-116.07% |
| ROE |
n/a |
| ROIC |
283.30% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 0.04 | 0.07 | 0.63 | 0.11 | 0.17 | 0.05 | 0.07 | 0.27 | 0.18 | 0.23 |
| Revenue Growth | -37.75% | -88.98% | 477.67% | -37.65% | 217.96% | -17.65% | -75.33% | 50.01% | -21.38% | - |
| Gross Profit | 0.03 | 0.05 | 0.59 | 0.07 | 0.12 | 0.03 | 0.06 | 0.27 | 0.18 | 0.21 |
| Operating Income | -0.54 | -0.60 | -0.36 | -0.84 | -1.08 | -1.17 | -0.76 | -1.32 | -1.23 | -0.80 |
| Net Income | -1.70 | 0.16 | -1.83 | -2.05 | -1.99 | -1.93 | -1.34 | -1.45 | -1.36 | -1.07 |
| Shares Outstanding | 3.01 | 2.86 | 2.60 | 2.37 | 2.28 | 2.23 | 2.21 | 2.17 | 2.03 | 1.80 |
| Earnings Per Share | -0.57 | 0.06 | -0.70 | -1.00 | -1.00 | -1.00 | -0.50 | -0.50 | -0.50 | -0.50 |
| Operating Cash Flow | -0.13 | -0.03 | -0.01 | -0.24 | -0.85 | -1.17 | -0.75 | -0.54 | -0.19 | 0.02 |
| Capital Expenditures | 0.08 | - | -0.02 | - | -0.01 | -0.07 | -0.11 | -0.03 | -0.09 | -0.14 |
| Free Cash Flow | -0.05 | -0.03 | -0.03 | -0.24 | -0.86 | -1.24 | -0.86 | -0.57 | -0.28 | -0.12 |
| Cash & Equivalents | 0.00 | 0.00 | 0.27 | 0.00 | - | 0.20 | 0.51 | 0.45 | 0.00 | 0.00 |
| Total Debt | 2.09 | 2.82 | 5.07 | 4.85 | 4.99 | 4.23 | 2.97 | 1.69 | 0.19 | 0.36 |
| Net Cash / Debt | -2.09 | -2.81 | -4.80 | -4.85 | -4.99 | -4.03 | -2.45 | -1.24 | -0.19 | -0.36 |
| Assets | 0.18 | 0.22 | 0.63 | 0.34 | 0.40 | 0.65 | 0.87 | 0.75 | 0.30 | 0.27 |
| Liabilities | 3.19 | 4.94 | 7.39 | 6.45 | 6.06 | 5.00 | 3.61 | 2.37 | 1.04 | 1.31 |
| Book Value | -3.01 | -4.72 | -6.76 | -6.11 | -5.66 | -4.35 | -2.74 | -1.62 | -0.74 | -1.03 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Skinvisible, Inc. |
| Country |
United States |
| Employees |
3 |
| CEO |
Terry H. Howlett |
Stock Information
| Ticker Symbol |
SKVI |
| Stock Exchange |
US OTC |
| Sector |
Consumer Defensive |
| Industry |
Household & Personal Products |
| Unique Identifier |
OTCMKTS: SKVI |
| IPO Date |
January 7, 1999 |
Description
Skinvisible, together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and others markets. The company offers sunless tanning and sunscreen products. Skinvisible, Inc. also licenses its products to manufacturers and marketers of brands internationally, as well as sells directly in the market; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was founded in 1998 and is based in Las Vegas, Nevada.